PATENT CLAIM ANALYSIS

Application Number: 15988802
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["435", "370000"]

Abstract:
The present invention discloses cryopreserved recombinant cells for screening drug candidates that transiently overexpress one or more drug transporter proteins and/or drug metabolizing enzymes. Advantageously, such cells provide a cost-efficient consumable product that streamlines the process of screening whether drug candidates are substrates or inhibitors of drug transporter proteins and/or drug metabolizing enzymes.

Claim (Index 27):
The process of  claim 24 , wherein:\n a population of the transiently transfected recombinant cells transiently overexpress the one or more genes encoding the drug transporter protein at the detectable level following thaw from cryopreservation, the detectable level following thaw from cryopreservation is the activity of the drug transporter protein towards a specific prototypical substrate for the drug transporter protein, and wherein the detectable level following thaw from cryopreservation is an uptake ratio of at least 5.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 93.0
- Lexical Diversity: 1.4359
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15163218', '15688942', '15988819', '15688983', '14972012']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8476389474492998
- 35 USC 102 Novelty (BERT): 0.7276504818029874
- Combined Prediction Score: 0.8356401008846686
- Mean Citation Score: 897.8125239999997
- Max Citation Score: 937.61475
- Similarity Product: 813.0544269577414

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test